🔗 Permalink

Inventor profile of:

Robert BABILON

City:

Boyertown, Pennsylvania

Country:

United States

Published Applications:

Last publication date:

2020-09-03

Top Assignees for applications by Robert BABILON

The entities that hold a legal rights for patent applications filed by inventor BABILON Robert:

Medicis Pharmaceutical Corporation 7 Scottsdale, AZ United States
Graceway Pharmaceuticals. LLC 7 Bristol, TN United States
Medicis Pharmaceutical Corporation 3 Bridgewater, NJ United States
Medicis Pharmaceutical Corporation 1 Scottsdae, AZ United States

Recent patent applications by BABILON Robert

Robert BABILON from Boyertown, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-09-03

US20200276182A1

Human necessities

2x2x2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75% imiquimod

#2 | 2016-10-20

US20160303111A1

Human necessities

2×2×2 week dosing regimen for treating acting keratosis with pharmaceutical compositions formulated with 3.75% imiquimod

#3 | 2013-08-15

US20130210855A1

Human necessities

2×2×2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75 % imiquimod

#4 | 2012-12-27

US20120329825A1

Human necessities

LOWER DOSAGE STRENGTH IMIQUIMOD FORMULATIONS AND SHORT DOSING REGIMENS FOR TREATING GENITAL AND PERIANAL WARTS

#5 | 2012-12-27

US20120329824A1

Human necessities

LOWER DOSAGE STRENGTH IMIQUIMOD FORMULATIONS AND SHORT DOSING REGIMENS FOR TREATING GENITAL AND PERIANAL WARTS

#6 | 2012-12-27

US20120329823A1

Human necessities

LOWER DOSAGE STRENGTH IMIQUIMOD FORMULATIONS AND SHORT DOSING REGIMENS FOR TREATING GENITAL AND PERIANAL WARTS

#7 | 2012-11-15

US20120289538A1

Human necessities

Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts

#8 | 2011-12-29

US20110319811A1

Human necessities

COMBINATION THERAPY WITH CRYOSURGERY AND LOW DOSAGE STRENGTH IMIQUIMOD TO TREAT ACTINIC KERATOSIS

#9 | 2011-10-27

US20110263637A1

Human necessities

UP TO SIX WEEKS DOSING REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 3.75% IMIQUIMOD

#10 | 2011-10-27

US20110263636A1

Human necessities

3 x 3 x 3 WEEK DOSING REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 3.75 % IMIQUIMOD

#11 | 2011-10-27

US20110263635A1

Human necessities

Method of treating actinic keratosis with 3.75% imiquimod cream

#12 | 2011-10-27

US20110263634A1

Human necessities

LOWER DOSAGE STRENGTH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 2.5% IMIQUIMOD

#13 | 2011-10-27

US20110263633A1

Human necessities

UP TO SIX WEEKS TREATMENT REGIMEN FOR TREATING ACTINIC KERATOSES WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 2.5% IMIQUIMOD

#14 | 2011-10-20

US20110257219A1

Human necessities

LOWER DOSAGE STRENGTH PHARMACEUTICAL COMPOSITIONS FORUMLATED WITH 3.75% IMIQUIMOD

#15 | 2011-10-20

US20110257218A1

Human necessities

2×2×2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75 % imiquimod

#16 | 2011-10-20

US20110257217A1

Human necessities

3 x 3 x 3 WEEK TREATMENT REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 2.5% IMIQUIMOD

#17 | 2011-10-20

US20110257216A1

Human necessities

2×2×2 week treatment regimen for treating actinic keratosis with pharmaceutical compositions formulated with 2.5% imiquimod

#18 | 2011-08-25

US20110207766A1

Human necessities

LOWER DOSAGE STRENGTH IMIQUIMOD FORMULATIONS AND SHORT DOSING REGIMENS FOR TREATING GENITAL AND PERIANAL WARTS

#19 | 2011-01-27

US20110021555A1

Human necessities

LOWER DOSAGE STRENGTH IMIQUIMOD FORMULATIONS AND SHORTER DOSING REGIMENS FOR TREATING ACTINIC KERATOSES

InventorID:

391315 ⎘